COMMUNIQUÉS West-GlobeNewswire

Cybrexa Therapeutics Appoints Keely Zipp as Vice President of Marketing
08/10/2018
Adds oncology marketing and strategy experience from Incyte Corporation and GlaxoSmithKline NEW HAVEN, Conn., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an early-stage biotechnology company developing a new [...]
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder
08/10/2018
Twenty sites across the U.S. are the first to receive the BrainsWay Deep transcranial magnetic stimulation system (Deep TMS) for obsessive-compulsive disorder (OCD) HACKENSACK, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- [...]
CLS Holdings USA, Inc. Announces up to US$40 Million Brokered Private Placement
08/10/2018
This is not an offer for sale, or solicitation of an offer to buy, nor may there be any sale in the United States or to, or for the account or benefit of, any U.S. Person (as defined in Regulation S under the U.S. [...]
Allakos Presents Data from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting
08/10/2018
SAN CARLOS, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the treatment of eosinophil and mast cell related [...]
Soleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual Conference
08/10/2018
Oral presentation on DCCR’s mechanism of action in treating hyperphagia Poster presentation on DCCR’s safety profile and implications for PWS Phase III study design REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE [...]
CDx Diagnostics to Present New WATS3D Data Confirming Crypt Dysplasia as a Risk Factor for Esophageal Cancer in Patients With Barrett’s Esophagus
08/10/2018
- Data Presented at ACG 2018 Presidential Plenary Session Underscores the Value of Using WATS 3D to Ensure Accurate Risk Stratification of BE Patients to Reduce Esophageal Cancer Deaths - SUFFERN, N.Y., Oct. 08, 2018 ( [...]
Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
08/10/2018
EAST RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage [...]
Inovio Successfully Develops First DNA-Encoded Monoclonal Antibody (dMAb™) Checkpoint Inhibitor and Demonstrates Tumor Shrinkage in Preclinical Studies
08/10/2018
Advancement highlighted in prestigious AACR journal Cancer Research PLYMOUTH MEETING, Pa., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today the successful animal testing of DNA [...]
Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan
08/10/2018
Expanded license agreement adds SB206 for the treatment of viral skin infections Novan to receive upfront cash consideration of approximately 1.25 billion JPY (~$11.0 million), payable over the next 12 months Milestone [...]
Cocrystal Pharma Announces Clinical Trial Agreement for Investigator-Initiated Phase 2a Study in Hong Kong of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
08/10/2018
- Humanity & Health Research Centre to conduct Phase 2a study evaluating CC-31244 for the treatment of hepatitis C - Asia market represents one of the largest hepatitis C virus carrier populations in the world [...]
Public Company Becomes Newest Entrant In Alarm Industry; NuLife Expands from Life Sciences to Life Safety
08/10/2018
NEWPORT BEACH, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- NuLife Sciences, Inc . (OTCQB: “NULF”) announced today that it has successfully closed its previously announced merger with two Louisiana-based electronic [...]
Menlo Therapeutics Announces Results from a Phase 2 Clinical Trial of Serlopitant for the Treatment of Refractory Chronic Cough
08/10/2018
Serlopitant fails to demonstrate efficacy relative to placebo on primary and secondary endpoints REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO) a late-stage [...]
Novo Nordisk A/S - Share repurchase programme
08/10/2018
Bagsværd, Denmark, 8 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Pacific Biosciences Releases Highest-Quality, Most Contiguous Individual Human Genome Assembly to Date
08/10/2018
Diploid Assembly of a Puerto Rican Female Adds a Rich Resource to Population-Specific Reference Genomes MENLO PARK, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the [...]
Spark Therapeutics Announces New Preclinical Data for Pompe Disease Gene Therapy Candidate
08/10/2018
Data from IND-enabling studies in three species support moving SPK-3006 into the clinic in 2019 PHILADELPHIA, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated, commercial gene [...]
FSD Pharma: Strategic Investments & Clean Balance Sheet -- CFN Media
08/10/2018
SEATTLE, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
TG Therapeutics, Inc. Highlights Schedule of Events at the Upcoming 34th Congress of ECTRIMS
08/10/2018
Final ublituximab phase 2 Multiple Sclerosis data to be featured in an oral presentation, Thursday, October 11, 2018, 16:51-17:03 CEST ECTRIMS data review conference call to be held Thursday, October 11, 2018, 19:30 [...]
Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018
08/10/2018
LAKE FOREST, Ill., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release third-quarter 2018 financial results on Thursday, November 8, 2018, after the close of [...]
PhaseBio Launches Roadshow for Initial Public Offering
08/10/2018
MALVERN, Pa. and SAN DIEGO, Oct. 08, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (“PhaseBio”), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]

Pages